Home > Healthcare > Biotechnology > Biopharma > Bioink Market

Bioink Market Trends

Report ID: GMI9118
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Bioink Market Trends

Ongoing advancements in bioprinting technology, such as improved printing resolution, faster speeds, and the ability to use multiple materials, are expanding the potential and applications of bioink. As bioprinting technology becomes more refined and widely accessible, the demand for compatible bioinks is increasing, driving market growth throughout the forecast period. Additionally, the rise in R&D activities focused on developing more effective bioinks, along with the growing use of bioinks in tissue engineering and regenerative medicine, are expected to further propel market growth.
For instance, in November 2021, Coll Plant Biotechnologies, a regenerative and aesthetic medicine company, announced the launch of Collink.3D, a recombinant human collagen (rhCollagen)-based bioink solution for 3D bioprinting. Collink.3D can be applied in various areas, including drug discovery, drug screening, tissue testing, as well as the development and manufacturing of transplantable tissues, scaffolds, and organs. This represents a potential multi-billion-dollar market opportunity, further boosting market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The bioink industry was valued at USD 70.4 million in 2023 and is estimated to grow at a 12.5% CAGR from 2024 to 2032, driven by increasing applications in biomedical research and therapy, and a rising incidence of chronic diseases and organ failures.

The natural bioinks segment recorded USD 60.7 million in 2023 and is expected to dominate the market due to their biocompatibility, non-toxicity, and sustainability.

The North America bioink market recorded a substantial share of 43.6% in 2023 and is expected to maintain its dominance throughout the forecast period. This growth is attributed to the availability of technologically advanced bioink products, such as improved printing resolution, multi-material printing capabilities, and integrated bioprinting systems.

Key players in the bioink industry include Allevi, Inc. (3D Systems), Axolotl Biosciences, BIO INX, CELLLINK (BICO), CollPlant Biotechnologies Ltd, Foldink, Gelomics, INNOREGEN, Inc., and Merck KGaA.